1-L Prep Boosts Quality, Not Adequacy - Quiz - MDSpire

1-L Prep Boosts Quality, Not Adequacy

Randomized trial in hospitalized patients found improved high-quality bowel cleansing with 1-L regimen, though primary endpoint differences were not statistically significant

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

Original Source(s)

1-L Prep Boosts Quality, Not Adequacy

  • by Andrea Surnit

  • May 5, 2026

Related Content

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

Prehabilitation Program May Benefit Patients Undergoing CRC Surgery

Structured implementation increased participation and improved preoperative fitness, while postoperative complication and mortality rates remained similar across groups.